Fraboc, more accurately written as FRA-BOC, refers to Familial Risk Assessment – Breast and Ovarian Cancer, a former Australian online clinical tool designed to help health professionals assess a patient’s risk of breast and ovarian cancer using family-history information. It was not a cancer diagnosis, genetic test, or treatment. Cancer Australia now lists FRA-BOC as a former tool and notes that newer breast cancer risk-assessment resources are available.
The term can still appear in older medical resources, archived documents, clinical discussions, and searches about inherited cancer risk. Understanding what Fraboc originally meant is useful because it helps separate an older risk-assessment system from the tools and clinical approaches used today.
What Is Fraboc?
Fraboc is the informal spelling often used for FRA-BOC, short for Familial Risk Assessment – Breast and Ovarian Cancer.
Cancer Australia describes FRA-BOC as an online tool created for health professionals, including general practitioners and nurses, to assess breast and ovarian cancer risk based on a patient’s family history. Its purpose was to support clinical risk assessment rather than provide a diagnosis.
Family history can be important when considering breast and ovarian cancer risk. Patterns such as several relatives with relevant cancers, cancers occurring at younger ages, or particular combinations of breast and ovarian cancer may indicate that a person needs more detailed assessment.
The key distinction is simple: FRA-BOC assessed risk; it did not determine that a person had cancer.
Fraboc Meaning in the Medical Context
The medical meaning of Fraboc becomes clearer when the acronym is separated into its original words.
| Term | Meaning |
|---|---|
| FRA | Familial Risk Assessment |
| BOC | Breast and Ovarian Cancer |
| FRA-BOC | Familial Risk Assessment – Breast and Ovarian Cancer |
| Primary purpose | Assess cancer risk associated with family history |
| Original users | Health professionals |
| Current status | Former tool; no longer available through Cancer Australia |
Cancer Australia currently states that the FRA-BOC tool is no longer available on its website.
That status matters because someone searching for Fraboc today may assume it is an active consumer health calculator. It should not be treated that way simply because older pages or documents still reference its name.
How Fraboc Was Used
The basic purpose of FRA-BOC was to help health professionals organize and interpret information about a patient’s family history of breast and ovarian cancer.
Rather than looking at a single relative in isolation, familial risk assessment considers the broader pattern. Information about affected relatives, their relationship to the patient, the type of cancer, and age at diagnosis can all be relevant when determining whether more detailed evaluation is appropriate.
Older Australian clinical material describes FRA-BOC as a tool for helping professionals distinguish women at population-level risk from those whose family history warranted further assessment or referral.
This approach reflects an important principle in cancer risk assessment: family history can guide the next clinical step, but it does not automatically mean someone carries an inherited cancer-causing gene.
Why Family History Matters in Breast and Ovarian Cancer
Family history is one part of a much larger picture when evaluating cancer risk.
Cancer Australia notes that breast cancer risk is influenced by numerous factors, including family history, reproductive factors, breast density, lifestyle factors and inherited gene faults. Having a risk factor does not mean that a person will definitely develop cancer.
Some family-history patterns can be more significant than others. For example, multiple relatives affected by breast or ovarian cancer, particularly when cancers occur at younger ages, can warrant a closer look by a healthcare professional.
The purpose of an assessment such as FRA-BOC was therefore not to label someone as having cancer. It was to help determine whether their history suggested average, increased, or potentially high familial risk and whether further professional assessment was appropriate.
What Information Was Relevant to a Fraboc Assessment?
A familial risk assessment generally depends on having reasonably accurate family-health information.
Useful details can include:
- Which relatives had breast or ovarian cancer
- Whether relatives were on the maternal or paternal side
- The type of cancer diagnosed
- The age at which a relative was diagnosed
- Whether several relatives were affected
- Whether a person had a personal history that changed the interpretation of their risk
Australian clinical guidance has historically emphasized patterns involving multiple affected relatives, younger ages at diagnosis, bilateral breast cancer, breast and ovarian cancer in the same individual, and other features when considering hereditary cancer risk.
That is why someone preparing for a risk discussion with a doctor may find it helpful to gather as much reliable family-history information as possible.
Fraboc and Cancer Risk Categories
One important feature of the former FRA-BOC approach was its use in categorizing breast cancer risk according to family history.
Older Australian clinical resources describe three broad risk levels for breast cancer, with higher-risk patterns potentially leading to additional assessment or referral.
| Risk concept | What it generally means |
|---|---|
| Population or average risk | Family history does not indicate a substantially increased familial risk |
| Moderately increased risk | Family-history pattern suggests greater-than-average risk |
| Potentially high risk | Family history may warrant specialist assessment and individualized management |
These categories should not be interpreted as personal medical conclusions without a proper assessment. Risk estimates can change when additional family, genetic, medical, reproductive, or lifestyle information becomes available.
Was Fraboc a Genetic Test?
No. FRA-BOC was not itself a genetic test.
This distinction is especially important because the term is closely associated with hereditary cancer risk.
A risk-assessment tool can help identify people who may benefit from further evaluation, but genetic testing is a separate clinical process. Cancer Australia notes that women with a strong family history may be referred to a family cancer clinic, where a more precise risk assessment and discussion about genetic testing may take place.
Genetic testing may be considered in appropriate circumstances, but whether testing is useful depends on a person’s individual and family history and should be discussed with an appropriately qualified healthcare professional.
Why Fraboc Is No Longer the Current Tool
The name Fraboc may still appear in older Australian medical information, but the original tool is no longer available through Cancer Australia.
Cancer Australia now points users toward more current breast cancer risk-assessment resources, including iPrevent, which is described as a validated breast cancer risk assessment and risk-management decision-support tool.
BreastScreen Queensland also confirms that the former FRA-BOC tool is no longer available on the Cancer Australia website and identifies iPrevent as a current validated option for breast cancer risk assessment.
This is a useful reminder when reading older health information online: a tool can remain well known in archived material even after clinical resources have moved to newer systems.
Fraboc vs iPrevent
Fraboc and iPrevent are related through the broader goal of breast cancer risk assessment, but they should not be treated as identical tools.
| Feature | FRA-BOC / Fraboc | iPrevent |
|---|---|---|
| Full name | Familial Risk Assessment – Breast and Ovarian Cancer | iPrevent Breast Cancer Risk Assessment |
| Historical/current status | Former tool | Current risk-assessment resource |
| Main focus | Familial breast and ovarian cancer risk | Breast cancer risk assessment and management |
| Intended setting | Health professional assessment | Risk and prevention discussions involving women and doctors |
| Current Cancer Australia status | No longer available | Recommended current resource |
| Genetic testing | Not a genetic test | Not itself a genetic test |
Cancer Australia describes iPrevent as a validated breast cancer risk-assessment and risk-management decision-support tool intended to support prevention and screening discussions between women and their doctors.
How iPrevent Fits Into Current Risk Assessment
For people searching for Fraboc because they want to understand their current breast cancer risk, looking for an up-to-date assessment method is more appropriate than trying to locate the retired FRA-BOC system.
iPrevent uses relevant personal, family, reproductive, and other risk information to estimate breast cancer risk and support discussions about prevention and screening. Breast Cancer Trials explains that the tool uses validated risk models and provides personalized information that can be discussed with a doctor.
BreastScreen Queensland currently describes three broad breast cancer risk categories used with iPrevent:
- Average risk: less than 1.5 times population risk
- Moderate risk: 1.5 to 3 times population risk
- High risk: more than 3 times population risk
These are assessment categories rather than predictions that cancer will or will not occur.
What Should You Do If You Found “Fraboc” in an Old Medical Document?
Finding the word Fraboc in an older document does not necessarily mean that you need to locate the old tool.
A practical first step is to identify when the document was written and why FRA-BOC was mentioned. The reference may simply indicate that a clinician previously used the tool to assess family-history information.
For a current concern about breast or ovarian cancer risk, discuss the document with your doctor and explain your family history as accurately as possible. Cancer Australia recommends speaking with a doctor when there are concerns about breast cancer risk and notes that some people with a strong family history may benefit from referral to a family cancer clinic.
Do not assume that an old risk category remains accurate forever. Risk assessment can depend on updated personal information, changes in guidelines, additional family diagnoses, and newer validated tools.
Common Misunderstandings About Fraboc
Is Fraboc a cancer diagnosis?
No. FRA-BOC was a familial risk-assessment tool, not a diagnostic test. Its purpose was to help assess risk based on family history.
Is Fraboc still available?
The original FRA-BOC tool is no longer available on the Cancer Australia website. Current resources such as iPrevent are used for contemporary breast cancer risk assessment.
Does having a family history mean someone will get cancer?
No. Family history can increase risk, but it does not guarantee that a person will develop breast or ovarian cancer. Cancer Australia notes that people may have risk factors and never develop cancer, while others can develop cancer without an obvious known risk factor.
Is Fraboc the same as genetic testing?
No. A familial risk assessment and genetic testing are different things. A risk assessment may help determine whether further specialist evaluation or genetic counseling should be considered.
What should I use instead of Fraboc today?
For current breast cancer risk assessment in Australia, Cancer Australia identifies iPrevent as a validated resource. A doctor can also help determine whether a family cancer clinic or other specialist assessment is appropriate.
Frequently Asked Questions About Fraboc
What does Fraboc stand for?
Fraboc refers to FRA-BOC, meaning Familial Risk Assessment – Breast and Ovarian Cancer. It was a former Australian clinical tool used to help health professionals assess cancer risk based on family history.
Who was Fraboc designed for?
FRA-BOC was designed for health professionals, including general practitioners and nurses, rather than being a general consumer diagnostic test.
Was Fraboc used to detect cancer?
No. It was intended for risk assessment, not for diagnosing breast or ovarian cancer.
Can I still use the original Fraboc tool?
The original FRA-BOC tool is no longer available through Cancer Australia. More recent validated tools are now used for breast cancer risk assessment.
What is the modern alternative to Fraboc?
Cancer Australia currently points to iPrevent for breast cancer risk assessment and risk-management discussions. People with significant family-history concerns may also be referred for specialist assessment.
Final Takeaway
Fraboc is best understood as FRA-BOC, the former Familial Risk Assessment – Breast and Ovarian Cancer tool used in Australia. Its role was to help health professionals consider a patient’s familial risk of breast and ovarian cancer rather than diagnose cancer or perform genetic testing.
Although the original tool has been retired, the underlying reason people search for Fraboc remains relevant: understanding how family history may affect cancer risk. Today, current validated tools such as iPrevent and professional assessment through a GP or family cancer clinic provide a more appropriate route for evaluating present-day risk.
For anyone who has encountered Fraboc in an old medical record or is concerned about a family history of breast or ovarian cancer, the most useful next step is to take that information to a qualified healthcare professional and discuss a current risk-assessment approach.
Also Read: Hair Loss and Mental Health: How Hair Replacement Is Changing Men’s Confidence